Candioli Pharma

Candioli Pharma: Transforming Veterinary and Pharmaceutical Industries Since 1882

Candioli Pharma, established in 1882 by Dr. Attilio Candioli in Rome, has evolved into a prominent player in the pharmaceutical market. The company's consistent commitment to excellence in product development and manufacturing has facilitated its transition into a modern and state-of-the-art entity.

Over its illustrious 140-year history, Candioli Pharma has broadened its scope to include highly innovative products in the veterinary market, with a focus on pet health. The company's portfolio encompasses three distinct product lines catering to small animals, ornithology, and athletic horses, alongside its flagship product MOM, an antiparasitic for human treatments.

Their mission revolves around introducing groundbreaking solutions to veterinarians and pet owners, aiming to align the quality of life for animals with societal standards. This underscores the company's unwavering belief in the pursuit of uncompromising quality as the ultimate path to enhancing pets' well-being.

While specific details about their latest investment and investors are not available, Candioli Pharma's enduring legacy and strategic position within the manufacturing and pharmaceutical industries, coupled with its commitment to innovation and quality, make it an intriguing prospect for potential investment and partnership opportunities.

Based in Italy, Candioli Pharma stands as a testament to longstanding excellence and a beacon of promise for the future of veterinary and pharmaceutical sectors.